Company news
Microbix Biosystems Inc. (TSX:MBX) news
Every Microbix Biosystems Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Microbix Reports Results for Q3 Fiscal 2026
August 13, 2026
Microbix Schedules Release of Results for Q3 Fiscal 2026
August 6, 2026
Microbix Reports Results for H1 & Q2 2026
May 14, 2026
Microbix Schedules Release of Results for Q2 Fiscal 2026
May 7, 2026
Microbix Product Results Being Presented at 2026 PASCV
April 27, 2026
Microbix Engages with Diagnostics Industry Experts
April 20, 2026
Microbix Presenting at the 2026 Bloom Burton Conference
April 16, 2026
Microbix Exhibiting & Presenting at ESCMID Global 2026
April 15, 2026
Microbix Announces Annual Meeting Voting Results
March 26, 2026
Microbix Presents Reference-Material Innovations at EUROGIN
March 17, 2026
Microbix Reports Results for Q1 2026
February 12, 2026
Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs
February 10, 2026
Microbix Schedules Release of Results for Q1 Fiscal 2026
February 5, 2026
Microbix Presents Molecular Pathology Platform Results
February 4, 2026
Microbix Updates Investor Presentation on its Website
January 9, 2026
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing
January 7, 2026
Microbix Reports Results for Q4 and Fiscal 2025
December 18, 2025
Microbix Schedules Release of Results for Q4 Fiscal 2025
December 11, 2025
Microbix Launches New Products to Support H3N2 Flu Testing
December 10, 2025
Microbix Announces Initiation of Normal Course Issuer Bid
December 4, 2025
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
December 3, 2025
Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests
November 12, 2025
Microbix Addresses Cybersecurity Incident
November 5, 2025
Microbix Presenting at Muskoka Capital Event
September 25, 2025
Microbix Assisting EMQN with Second Genetic-Test EQA Program
September 23, 2025
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
September 17, 2025
Microbix Hosts Ontario Minister Stephen Crawford
September 3, 2025
Microbix Reports Results for Q3 Fiscal 2025
August 14, 2025
Microbix Schedules Release of Results for Q3 Fiscal 2025 Results Release and Webinar Discussion on Morning of August 14, 2025
August 7, 2025
Microbix Launches QUANTDx™ Characterized Reference Materials
July 29, 2025
Microbix Launches QUANTDx(TM) Characterized Reference Materials
July 29, 2025
Microbix Exhibiting & Presenting at ADLM
July 24, 2025
Microbix & Bulgaria’s NCIPD Execute Supply Agreement
July 8, 2025
Microbix & Bulgaria's NCIPD Execute Supply Agreement
July 8, 2025
Microbix Attending & Presenting at Asia Pacific POC 2025
June 17, 2025
Microbix Reports Results for Q2 Fiscal 2025
May 15, 2025
Microbix & Aurevia Introduce Novel EQA Scheme
May 13, 2025
Microbix Schedules Release of Results for Q2 Fiscal 2025
May 8, 2025
Microbix’s Clot-Buster Drug Project Advances
May 5, 2025
Microbix's Clot-Buster Drug Project Advances
May 5, 2025
Microbix Presenting at the 2025 Bloom Burton Conference
May 1, 2025
Microbix Exhibiting at ESCMID Global 2025
April 9, 2025
Microbix Provides Business Updates
April 8, 2025
Microbix Announces Annual and Special Meeting Voting Results
March 27, 2025
Microbix Further Optimizes Capital Usage and Availability
March 26, 2025
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
March 17, 2025
Microbix Hosts Ontario Premier Doug Ford & Team
February 27, 2025
Microbix Announces Issuance of Stock Options
February 26, 2025
Microbix Presenting at Investor Conference in B.C.
February 19, 2025
Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025
February 13, 2025